Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
STERIS plc (Ireland) Ordinary Shares
(NY:
STE
)
225.72
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Apr 1, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about STERIS plc (Ireland) Ordinary Shares
< Previous
1
2
3
4
5
Next >
NVIDIA To $225? Plus Raymond James Cuts PT On This Stock By 81%
November 11, 2022
Oppenheimer cut the price target on NVIDIA Corporation (NASDAQ: NVDA) from $250 to $225. Oppenheimer analyst Rick Schafer maintained an Outperform rating on the stock. NVIDIA shares rose 0.9% to...
Via
Benzinga
STERIS Announces Financial Results for Fiscal 2023 Second Quarter
November 09, 2022
From
STERIS plc
Via
GlobeNewswire
STERIS Declares $0.47 per share Dividend
November 02, 2022
From
STERIS plc
Via
GlobeNewswire
Buy These 2 Evergreen Growth Stocks Today to Beat the Bear Market Blues
October 30, 2022
Both have loyal and long-term customers, as well as plenty of accessible growth for years to come.
Via
The Motley Fool
STERIS to Host a Conference Call for Fiscal 2023 Second Quarter Financial Results on November 10, 2022
October 25, 2022
From
STERIS plc
Via
GlobeNewswire
Needham Downgrades This Medical Equipment Stock Due To Lawsuit Risk
September 23, 2022
Via
Benzinga
3 Fast-Growing Medical Dividend Stocks
October 17, 2022
Sometimes, the strongest payout growth can be found among the future Dividend Aristocrats, not the current ones.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2022
September 23, 2022
Upgrades
Via
Benzinga
Expert Ratings for Steris
August 04, 2022
Analysts have provided the following ratings for Steris (NYSE:STE) within the last quarter:
Via
Benzinga
Earnings Scheduled For May 11, 2022
May 11, 2022
Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter.
Via
Benzinga
Steris Q3 Sales Jump 50% To $1.2B, Revises FY22 Guidance
February 09, 2022
Steris plc (NYSE: STE)
Via
Benzinga
Earnings Scheduled For November 2, 2021
November 02, 2021
Companies Reporting Before The Bell • Thomson Reuters (NYSE:TRI) is expected to report quarterly earnings at $0.48 per share on revenue of $1.86 billion. •...
Via
Benzinga
AMD, SolarEdge Technologies And Some Other Big Stocks Moving Lower On Wednesday
August 03, 2022
Rocky Brands, Inc. (NASDAQ: RCKY) dipped 21.6% to $26.62 after the company reported worse-than-expected Q2 EPS results.
Via
Benzinga
Steris: Q1 Earnings Insights
August 02, 2022
Steris (NYSE:STE) reported its Q1 earnings results on Tuesday, August 2, 2022 at 04:30 PM. Here's what investors need to know about the announcement. Earnings Steris missed estimated earnings by 0.52%,...
Via
Benzinga
ShockWave Medical Stock Scores Relative Strength Rating Jump To 89
June 27, 2022
ShockWave Medical stock saw a positive improvement to its Relative Strength (RS) Rating on Monday, rising from 77 to 89.
Via
Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
June 27, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Earnings Scheduled For August 2, 2022
August 02, 2022
Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2022
July 14, 2022
Upgrades
Via
Benzinga
Ominous Death Cross Forms On Steris's Chart
June 17, 2022
If history is any guide, there may be trouble ahead for shares of Steris (NYSE:STE). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.
Via
Benzinga
ShockWave Medical Stock Shows Rising Price Performance With Jump To 91 RS Rating
June 13, 2022
On Monday, ShockWave Medical stock received an upgrade to its Relative Strength (RS) Rating, from 86 to 91.
Via
Investor's Business Daily
Steris: Q4 Earnings Insights
May 11, 2022
Steris (NYSE:STE) reported its Q4 earnings results on Wednesday, May 11, 2022 at 04:30 PM. Here's what investors need to know about the announcement. Earnings Steris beat estimated earnings by 0.99%,...
Via
Benzinga
Stocks That Hit 52-Week Highs On Thursday
April 07, 2022
On Thursday, 75 stocks made new 52-week highs. Interesting Highlights From Today's 52-Week Highs: The largest company by market cap to hit a new 52-week high...
Via
Benzinga
UnitedHealth, Vertex Lead Five Stocks Looking Healthy In A Weak Market
March 05, 2022
Health care stocks have some advantages in the current market environment.
Via
Investor's Business Daily
10 Biggest Price Target Changes For Thursday
February 10, 2022
Macquarie boosted the price target on Twilio Inc. (NYSE: TWLO) from $281 to $306. Twilio shares jumped 20.4% to $243.23 in pre-market trading.
Via
Benzinga
Recap: Steris Q3 Earnings
February 08, 2022
Steris (NYSE:STE) reported its Q3 earnings results on Tuesday, February 8, 2022 at 04:30 PM. Here's what investors need to know about the announcement. Earnings Steris beat estimated earnings by 7.61%,...
Via
Benzinga
Evoqua Water Technologies Closes Acquisition of Renal Business from STERIS
January 03, 2022
From
Evoqua Water Technologies
Via
Business Wire
Earnings Scheduled For February 8, 2022
February 08, 2022
Companies Reporting Before The Bell • Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion.
Via
Benzinga
Evoqua Water To Acquire Steris' Renal Business For $196.3M
December 20, 2021
Evoqua Water Technologies Corp (NYSE: AQUA) has agreed to acquire the assets of the renal business of Steris PLC (NYSE: STE) for $196.3 million. The...
Via
Benzinga
If You Invested $100 Over The Past 5 Years In This Stock, Here's How Much You Would Have Today
December 02, 2021
Steris (NYSE:STE) has outperformed the market over the past 5 years by 11.52% on an annualized basis. Buying $100.00 In STE: 5 years ago, an investor could have purchased 1.53...
Via
Benzinga
Steris (STE) Q2 2022 Earnings Call Transcript
November 03, 2021
STE earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.